Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial
Version of Record online: 7 MAY 2013
© 2013 John Wiley & Sons Ltd
Diabetes, Obesity and Metabolism
Volume 15, Issue 10, pages 931–937, October 2013
How to Cite
Bray, G. A., Smith, S. R., Banerji, M. A., Tripathy, D., Clement, S. C., Buchanan, T. A., Henry, R. R., Kitabchi, A. E., Mudaliar, S., Musi, N., Ratner, R. E., Schwenke, D. C., Stentz, F. B., Reaven, P. D. and DeFronzo, R. A. (2013), Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial. Diabetes, Obesity and Metabolism, 15: 931–937. doi: 10.1111/dom.12099
- Issue online: 9 SEP 2013
- Version of Record online: 7 MAY 2013
- Accepted manuscript online: 2 APR 2013 10:20AM EST
- Manuscript Accepted: 14 MAR 2013
- Manuscript Revised: 26 JAN 2013
- Manuscript Received: 21 DEC 2012
- Takeda Pharmaceutical Company
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.